Background Approximately 25% of thyroid nodule fine‐needle aspirates (FNAs) have
cytology that is indeterminate for malignant disease. Accurate risk stratification of these …

Importance Approximately 20% of fine-needle aspirations (FNA) of thyroid nodules have
indeterminate cytology, most frequently Bethesda category III or IV. Diagnostic surgeries can …

Importance Approximately 20% of thyroid nodules display indeterminate cytology. Molecular
testing can refine the risk of malignancy and reduce the need for diagnostic …

Context.—Approximately 15% to 30% of thyroid nodules that undergo fine-needle aspiration
are classified as cytologically indeterminate, presenting management challenges for …

Thyroid nodules are common in the adult population where a majority are benign and only
4.0% to 6.5% are malignant. Fine needle aspiration (FNA) is a key method used in the early …

Context.—Fine-needle aspiration of thyroid nodules is a reliable diagnostic method to
determine the nature of thyroid nodules. Nonetheless, indeterminate cytology diagnoses …

Background: Seventy-five percent of thyroid nodules with indeterminate fine-needle
aspiration (FNA) cytology are found to be benign postoperatively. A novel genomic test, the …

Background Approximately 15 to 30% of thyroid nodules evaluated by means of fine-needle
aspiration are not clearly benign or malignant. Patients with cytologically indeterminate …

Molecular fine-needle aspiration (FNA) cytology diagnostics has the potential to address the
inherent limitation of FNA cytology which is an indeterminate (atypia of undetermined …

Introduction: Molecular testing of fine-needle aspiration (FNA) results helps diagnose thyroid
cancer, although the additional cost of this adjunct has not been studied. We hypothesized …